The Board of Directors of the Global HIV Vaccine Enterprise today announced that Alan Bernstein, Ph.D. will step down after three and a half years as the inaugural executive director of the Enterprise Secretariat at the end of June 2011. The full announcement is below.
The Global HIV Vaccine Enterprise and the OCTAVE Project (Online Collaborative Training for AIDS Vaccine Evaluation), are accepting applications for a new workshop focused on adjuvants and their critical role in enhancing vaccine immunogenicity. This two-day workshop, which blends eLearning and face-to-face training, is the fourth in a series of six capacity-building workshops aimed at providing young and early-career investigators (YECIs) with the tools to further their careers in HIV vaccine research and development. The call for applications is below.
The Global HIV Vaccine Enterprise is accepting applications for its Let’s Talk HIV Prevention series from individuals and organizations around the world interested in hosting a community event to raise awareness of the exceptional progress and challenges in HIV prevention research. For more information, visit our web page: htt
The Global HIV Vaccine Enterprise and the OCTAVE Project (Online Collaborative Training for AIDS Vaccine Evaluation), in close collaboration with the Brazilian Ministry of Health (Department of STD, AIDS and Viral Hepatitis and the Oswaldo Cruz Foundation - FIOCRUZ) and the University of São Paulo- USP, is offering a new regional workshop blending online and face-to-face learning for young and early-career investigators (YECIs) from Latin America and is soliciting applications.
The YECI Committee of the Enterprise will be implementing several key initiatives in support of the Scientific Strategic Plan over the next few years. The Enterprise is looking for motivated, creative and enthusiastic YECIs to join the Committee to help shape and move these initiatives forward. The request for applications to join the Enterprise YECI Committee is below.
The AIDS Vaccine 2010 conference welcomed six 10th grade students from the Cesar Chavez Public Charter High School for Public Policy in September. The students and their teachers travelled from Washington, DC to Atlanta, Georgia to attend the conference. The 10th graders to attend the conference, interact with global health experts and learn about the progress and challenges in developing an HIV vaccine.
The Enterprise announced that the Harvard Center for AIDS Research (Harvard CFAR) and the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University will serve as the Local Host of AIDS Vaccine 2012. The conference will be held 9 - 13 September 2012 in Boston, Massachusetts. The full announcement is below.